Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Amlodipine impurity 6 is a specific impurity associated with Amlodipine, a calcium channel blocker. This compound is primarily utilized in analytical and quality control applications to ensure the purity of Amlodipine formulations. Its characterization is crucial for regulatory compliance and the development of safe and effective therapeutic agents. -
Drug Impurity
Amlodipine impurity 8 is a drug impurity associated with Amlodipine, a calcium channel blocker. This impurity may arise during the synthesis of Amlodipine and is important for quality control and regulatory compliance in pharmaceutical development. It can also be utilized in analytical studies to assess the purity and stability of Amlodipine formulations. -
Drug Impurity
Amlodipine Impurity 1 is a synthesized impurity associated with Amlodipine, a calcium channel blocker. It is utilized primarily in drug analysis and quality control to ensure the purity and safety of pharmaceutical formulations. This compound can serve as a reference standard in research and development, aiding in the identification and quantification of impurities in Amlodipine products. -
Drug Impurity
Clevidipine butyrate impurity 1 is a known impurity of Clevidipine butyrate, which is a calcium channel blocker used in the management of hypertension. This compound serves as a reference standard for analytical tests and quality control assessments in pharmaceutical development. Researchers can utilize this impurity to ensure the purity and safety of drug formulations containing Clevidipine butyrate. -
Endogenous Metabolite
N-Stearoyl Taurine is an endogenous metabolite that exhibits activity as a fatty acyl amide. It demonstrates the ability to activate members of the transient receptor potential (TRP) family of calcium channels, linking it to various physiological processes. This compound is primarily used in research applications related to lipidomics and neurobiology, particularly in studies investigating the role of amino-acyl endocannabinoids in the central nervous system. Its discovery in rat brain lipid profiles underscores its significance in the exploration of neuronal signaling pathways. -
Endogenous Metabolite
N-Lignoceroyl Taurine is an endogenous metabolite and taurine conjugate of lignoceric acid, identified through lipidomic analysis of bovine brain. This compound exhibits distinct biological activity as a substrate for fatty acid amide hydrolase (FAAH), with levels significantly elevated in FAAH knockout mice, indicating a potential role in lipid metabolism. Additionally, N-Lignoceroyl Taurine has been shown to activate transient receptor potential (TRP) calcium channels, including TRPV1 and TRPV4, highlighting its relevance in neurobiology and cellular signaling research. -
Biochemical Reagent
D-myo-Inositol-4,5-diphosphate sodium is a critical biochemical reagent that functions as a second messenger in cellular signaling pathways. It primarily targets calcium channels, facilitating the release of intracellular calcium when it binds to its receptor on the endoplasmic reticulum. This compound is valuable for research applications investigating signal transduction, calcium homeostasis, and cellular responses in various biological systems. -
Sodium-Calcium Exchanger Inhibitor
KB-R7943 is a selective inhibitor of the sodium-calcium exchanger, exhibiting an IC50 value of 5.1 µM. This compound is utilized as a valuable tool in studies involving cardiac and renal failure models, facilitating research into calcium homeostasis and its implications in heart and kidney function. -
Calcium Channel Blocker
Suloctidil is an orally active calcium channel blocker that primarily targets vasoconstriction pathways. It effectively antagonizes vasoconstriction induced by norepinephrine, angiotensin, and serotonin, while also inhibiting platelet function and exhibiting neuroprotective effects. Additionally, Suloctidil demonstrates antifungal activity against Candida albicans, influencing biofilm formation and virulence. This compound is applicable in research focused on vasospasm relief, antithrombosis, and treatment of superficial candidiasis. -
Calcium Channel Antagonist
CP-060 is a potent calcium channel antagonist that effectively inhibits calcium overload in cells. This compound also exhibits notable antioxidant properties and offers cardioprotective effects. CP-060 is valuable for research applications focused on cardiovascular diseases and cellular stress responses. -
Calcium Channel Inhibitor
McN5691 is a voltage-sensitive calcium channel inhibitor that selectively blocks calcium influx through L-type calcium channels. This action leads to reduced calcium-dependent cellular events, making it a valuable tool for investigating calcium signaling pathways. McN5691 is particularly useful in research focused on cardiovascular physiology and the modulation of muscle contraction mechanisms. -
Calcium Channel Chemical
α2δ ligand 1 selectively interacts with the α2δ-1 subunit of voltage-gated calcium channels. This compound is known to modulate calcium influx, which plays a crucial role in neuronal excitability and synaptic transmission. It is utilized in research applications focused on pain management, neurological disorders, and the exploration of synaptic plasticity. -
Calcium Channel Antagonist
Dopropidil is a calcium channel antagonist that modulates intracellular calcium levels. It exhibits anti-anginal properties and demonstrates significant anti-ischemic effects in various predictive animal models. This compound is valuable for research in cardiovascular pharmacology, particularly in the study of angina and ischemic heart disorders. -
Calcium Channel Antagonist
Darodipine is a potent calcium channel antagonist that selectively inhibits L-type calcium channels. This compound demonstrates significant biological activity by decreasing intracellular calcium levels, which can effectively reduce vascular smooth muscle contraction. Darodipine is primarily utilized in research applications focused on cardiovascular physiology, hypertension studies, and the exploration of calcium signaling pathways. -
Dihydropyridine Calcium Antagonist
(S)-Nimodipine is a potent dihydropyridine calcium antagonist known for its selective effect on calcium channels. It exhibits significant biological activity, primarily in the management of cerebrovascular disorders by improving cerebral blood flow. This compound is especially valuable in research focusing on neurological conditions and the effects of calcium modulation in neuronal tissue. -
Calcium Channel Blocker
Verapamil hydrochloride is a calcium channel blocker primarily targeting L-type calcium channels. It exhibits potent inhibitory activity on P-glycoprotein and CYP3A4, contributing to its pharmacological profile. This compound is widely utilized in research related to hypertension, cardiac arrhythmias, and angina, facilitating studies on cardiovascular function and drug metabolism. -
L-type Calcium Chanel Inhibitor
Diltiazem is an orally active L-type calcium channel blocker that exerts antihypertensive and antiarrhythmic effects. It is utilized in research related to cardiac arrhythmias, hypertension, and angina pectoris, making it valuable for studies focused on cardiovascular health. Its mechanism of action contributes to the modulation of calcium influx, which is critical in various cardiac and vascular functions. -
NMDA Receptor Inhibitor
Bupivacaine is an NMDA receptor inhibitor that modulates neuronal excitability by blocking sodium, L-calcium, and potassium channels. It exhibits potent inhibition of SCN5A channels, with an IC50 of 69.5 μM. This compound is primarily utilized in research focused on chronic pain mechanisms and therapeutic interventions. -
Calcium Channels Antagonist
Fluspirilene is a non-competitive antagonist of L-type calcium channels, demonstrating an IC50 of 0.03 μM. This compound exhibits significant antipsychotic activity, making it a valuable tool for research on schizophrenia and related neuropsychiatric disorders. Its long-acting injectable formulation facilitates studies on sustained pharmacological effects in therapeutic applications. -
T Calcium Channel Antagonist
Ulixacaltamide is a potent T-type calcium channel antagonist that demonstrates significant efficacy in modulating neurological disorders. It has been shown to slow the progression of epilepsy and effectively reduce tremors in an alkaline tremor animal model. Additionally, Ulixacaltamide reverses thermal hyperalgesia, providing a mechanism for pain relief in various preclinical settings. This compound is valuable for research applications focusing on neurological function and pain management. -
SERCA Blocker
JTV-519 hemifumarate is a selective blocker of the sarcoplasmic reticulum Ca2+-stimulated ATPase (SERCA), with additional activity as a partial agonist of ryanodine receptors in striated muscle. It exhibits antiarrhythmic and cardioprotective properties, making it a valuable tool for research on cardiac function and rhythm disorders. This compound is useful in studies exploring calcium handling in myocardial cells and its implications for heart disease therapies. -
T-type Calcium Channel Blocker
TTA-P2 is a selective T-type calcium channel blocker with a primary mechanism of inhibiting calcium influx through T-type channels, exhibiting an IC50 of 22 nM. This compound demonstrates significant biological activity by reducing mechanical hypersensitivity and alleviating both acute and chronic pain. Additionally, TTA-P2 lowers firing rates in neurons associated with temporal lobe epilepsy, effectively controlling synaptically evoked burst firing. Research applications include investigations into neurological disorders such as tremor and absence epilepsy. -
Calcium Channel Inhibitor
Tetracaine hydrochloride is a calcium channel inhibitor that effectively blocks the voltage-sensitive release of Ca2+ from the sarcoplasmic reticulum. This compound exhibits significant biological activity and is primarily utilized in topical applications within ophthalmology, as well as serving as an antipruritic agent. Its mechanism of action makes it valuable for research in pain relief and modulation of calcium signaling pathways. -
Neuroprotective Compound
REM127 is a neuroprotective small molecule that modulates calcium homeostasis in cells. It effectively restores calcium balance in cellular models affected by the pathological accumulation of tau protein, demonstrating potential to mitigate synaptic and cognitive deficits in Alzheimer's disease models. REM127 is capable of crossing the blood-brain barrier and may slow the progression of amyloid-beta and tau protein pathologies. This compound is suitable for research applications in neurodegenerative diseases. -
SERCA2a Activator
SERCA2a Activator 1 is an activator of the sarco/endoplasmic reticulum Ca2+-dependent ATPase 2a (SERCA2a). This compound alleviates the inhibitory effects of phospholamban, thereby improving both systolic and diastolic cardiac functions. SERCA2a Activator 1 is primarily utilized in research related to heart failure and cardiac physiology. -
Calcium Ions Activator
Calcium citrate tetrahydrate is a calcium ions activator that efficiently releases calcium ions, enhancing biological activity in various applications. Its rapid solubility and ability to maintain elevated calcium ion concentrations make it particularly useful for research focused on bone formation and mineralization. This reagent is essential for studies investigating calcium-related signaling pathways and the effects of calcium on cellular processes. -
Calcium Channel Blocker
Prenylamine is a calcium channel blocker belonging to the amphetamine chemical class. It acts by inhibiting calcium influx through voltage-gated calcium channels, leading to vasodilation. This compound has potential applications in the research of cardiovascular conditions, particularly angina pectoris, by modulating vascular tone and reducing myocardial oxygen demand. -
Stable Isotope
Verapamil-d3 hydrochloride is a deuterium-labeled derivative of the calcium channel blocker, verapamil hydrochloride. It serves as a potent inhibitor of P-glycoprotein (P-gp) and CYP3A4, facilitating detailed pharmacological studies. This stable isotope is primarily utilized in research related to hypertension, cardiac arrhythmias, and angina, providing insight into drug metabolism and transport mechanisms in various biological systems. -
Calcium Receptor Activator
γ-Glutamylserine (γ-Glu-Ser) is a calcium receptor activator that plays a critical role in various cellular signaling pathways. This compound exhibits potential neuroprotective effects, making it relevant for research in Parkinson's disease. Additionally, γ-Glutamylserine may be utilized in studies focused on metabolic disorders, including diabetes and obesity. -
Phenylalkylamine Calcium Antagonist
Gallopamil hydrochloride is a phenylalkylamine calcium antagonist that exhibits potent antiarrhythmic and vasodilatory properties. It effectively inhibits acid secretion in a concentration-dependent manner, with an IC50 value of 10.9 μM. This compound is utilized in various research applications focused on cardiovascular function and gastrointestinal acid regulation. -
Calcium Channel
D-myo-Inositol-1,3,4,5-tetraphosphate sodium functions as a signaling molecule by regulating calcium channels. It is produced through the phosphorylation of inositol 1,4,5-trisphosphate by inositol 1,4,5-triphosphate 3-kinase. This compound is utilized in research focused on cellular signaling pathways, particularly those involving calcium mobilization and inositol phosphate metabolism. Its key biological activity makes it valuable for studies exploring neurotransmission, smooth muscle contraction, and other calcium-dependent processes. -
Calcium Channel Inhibitor
Lidoflazine is a potent inhibitor of calcium channels, specifically known for its high affinity blockade of the HERG potassium channel. This compound exhibits antianginal properties, making it relevant in studies related to cardiac function and arrhythmias. Notably, Lidoflazine is associated with a risk of QT interval prolongation and ventricular arrhythmia, which underscores its importance in pharmacological research aiming to understand cardiovascular safety profiles. -
Calcium Channel
PPZ2 is a diacylglycerol (DAG)-activated agonist of the TRPC3, TRPC6, and TRPC7 calcium channels. It promotes neuronal development and survival through its ability to elicit cation currents and calcium ion (Ca(2+)) influx in cultured central neurons in a dose-dependent manner. PPZ2 induces BDNF-like neurite outgrowth and provides neuroprotection, effects that are negated following TRPC channel knockdown or inhibition. Additionally, PPZ2 enhances the activation of the calcium-dependent transcription factor cAMP response element binding protein, highlighting the role of calcium signaling in its neurotrophic actions. -
Calcium Channel Inhibitor
Pranidipine is a potent, long-acting 1,4-dihydropyridine calcium channel inhibitor, specifically designed to modulate calcium influx in vascular smooth muscle cells. Its primary biological activity involves the reduction of blood pressure, making it an effective antihypertensive agent. This compound is widely used in cardiovascular research to investigate mechanisms underlying hypertension and to evaluate therapeutic strategies for managing elevated blood pressure. -
Calcium Influx Inhibitor
Carboxyamidotriazole Orotate is an orotate salt of Carboxyamidotriazole, a potent inhibitor of calcium influx. It acts primarily as a cytostatic agent targeting nonvoltage-operated calcium channels and disrupting calcium-mediated signaling pathways. This compound demonstrates notable anti-tumor, anti-inflammatory, and antiangiogenic properties, making it valuable in cancer research and the study of inflammatory diseases. -
L-type calcium channel Blocker
(R)-Nimodipine is an L-type calcium channel blocker that effectively penetrates the blood-brain barrier, with an IC50 value of 5 nM. By inhibiting calcium channels on the hypothalamic-pituitary-adrenal axis, (R)-Nimodipine reduces corticosterone release, thereby mitigating memory impairment and behavioral abnormalities associated with immobilization stress. This compound is frequently utilized in research focused on aneurysmal subarachnoid hemorrhage, cerebral ischemia, epilepsy, age-related neurodegenerative diseases, and the effects of alcohol intoxication. -
Calcium Channel Blocker
Nemadipine-A is a selective inhibitor of the EGL-19 L-type calcium channel. This compound demonstrates the ability to sensitize TRAIL-resistant cancer cells to TRAIL-mediated apoptosis. It is primarily utilized in research focused on cancer therapy and calcium signaling pathways. -
Calcium Channel Blocker
Methyl homoveratrate functions as a voltage-sensitive calcium channel blocker. This compound serves as a metabolite of RWJ-26240 and can be detected in plasma, urine, and fecal extracts. Its role in calcium channel inhibition makes it a valuable tool for investigating calcium signaling pathways and related physiological processes in various research applications. -
Calcium Channel Antagonist
Praeruptorin C serves as a calcium channel antagonist, exhibiting a pD2′ value of 5.7. Derived from Peucedanum praeruptorum, this bioactive compound plays a significant role in modulating calcium influx across cellular membranes. Research applications include studies on cardiovascular function and smooth muscle contraction, making it a valuable tool for investigating calcium-related physiological processes. -
Ligand for the α2δ Subunit of Voltage-gated Calcium Channels
Crisugabalin is a selective ligand targeting the α2δ subunit of voltage-gated calcium channels, exhibiting an IC50 of 3.96 nM in rat models. This compound effectively inhibits the binding of [3H]gabapentin to the α2δ subunit, leading to reduced calcium influx and decreased neuronal excitability, ultimately impairing nociceptive transmission. Crisugabalin has demonstrated efficacy in alleviating mechanical allodynia and various pain models, including neuropathic and inflammatory pain. Its applications are relevant in research contexts involving chronic pain syndromes such as diabetic neuropathy, fibromyalgia, and postherpetic neuralgia. -
Calcium Channel Antagonist
(+)-Niguldipine hydrochloride is a calcium channel antagonist that effectively induces vasodilation by inhibiting calcium influx through cell membranes. This compound demonstrates significant biological activity by antagonizing U-46619-induced coronary vasoconstriction in guinea pig Langendorff heart preparations, with a pID50 value of 11.37. Additionally, it binds to calcium channels in guinea pig skeletal muscle membranes with a Ki of 9.75 and exhibits blood pressure-lowering effects in spontaneously hypertensive rats, with a pED30 of 7.1. (+)-Niguldipine hydrochloride is utilized in research related to cardiovascular diseases, including hypertension, angina pectoris, and arrhythmias. -
Calcium Channel Antagonist
Clopimozide is a calcium channel antagonist that inhibits [3H]nitrendipine binding with an IC50 value of 17 nM. This orally active antipsychotic agent is utilized in research to investigate both negative and positive symptoms of schizophrenia, contributing to a deeper understanding of the neurobiological mechanisms underlying this disorder. Its selective action on calcium channels allows for targeted studies in pharmacology and therapeutics related to schizophrenia. -
Calcium Channel Antagonist
BTT-266 is a calcium channel antagonist that functions by inhibiting the interaction between CaVα1-AID and CaVβ3, exhibiting a Ki value of 1.4 μM. It effectively modulates the activation of voltage-dependent CaV2.2 channels. BTT-266 demonstrates analgesic properties in models of neuropathic pain, making it a valuable tool for research into pain modulation and potential therapeutic applications. -
Calcium Channel
2-Chloro-ATP sodium is an analog of ATP that acts as an antagonist of the purinergic P2Y1 receptor, inhibiting intracellular calcium mobilization induced by ADP in Jurkat cells with a Ki of 2.3 μM. Additionally, it serves as an agonist for the purinergic P2X receptor, generating inward currents in HEK293 cells with varying affinities (EC50 of 0.5 and 2.5 μM). This compound also induces concentration-dependent relaxation of precontracted guinea pig cecal strips. Furthermore, 2-Chloro-ATP sodium is utilized to investigate substrate specificity among cyclic nucleotide-dependent protein kinases, including protein kinase A (PKA) and PKG. -
Calcium Channel Inhibitor
Nothofagin is a dihydrochalcone that acts as a calcium channel inhibitor. By blocking calcium influx, it downregulates NF-κB translocation, providing a mechanism to modulate inflammatory responses. This compound exhibits antioxidant properties and has potential applications in research related to septic responses and vascular inflammation. -
Calcium Channel Blocker
MONIRO-1 is a selective inhibitor of T-type and N-type calcium channels, demonstrating IC50 values of 34 µM, 3.3 µM, 1.7 µM, and 7.2 µM against hCav2.2, hCav3.1, hCav3.2, and hCav3.3, respectively, while exhibiting minimal activity against L-type calcium channels. Its ability to modulate calcium influx makes MONIRO-1 a valuable tool for research into pain pathways and epilepsy mechanisms. This compound is instrumental for studies focused on the pharmacological modulation of calcium channels in neuronal excitability. -
SERCA Inhibitor
CAD204520 dihydrochloride is a selective SERCA inhibitor with an IC50 of 0.34 μM. This compound specifically targets mutated NOTCH1 proteins, demonstrating significant relevance in the study of T-cell acute lymphoblastic leukemia (T-ALL) and mantle cell lymphoma (MCL). It is a valuable tool for research investigating the therapeutic potential and mechanisms of these cancers. -
SERCA Inhibitor
CAD204520 is a selective inhibitor of the Sarcoplasmic Reticulum Calcium ATPase (SERCA), demonstrating an IC50 value of 0.34 μM. This compound specifically targets mutated NOTCH1 proteins more effectively than wild-type, making it a valuable tool for studying T-cell acute lymphoblastic leukemia (T-ALL) and mantle cell lymphoma (MCL). CAD204520 is suitable for research aimed at understanding the molecular mechanisms and therapeutic strategies in these malignancies. -
Calcium Channel
Ned-K is a nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist that targets calcium channels. It has been shown to effectively attenuate simulated ischemia and reperfusion (sIR)-induced calcium oscillations in cardiomyocytes. This compound serves as a valuable tool for research in cardiac physiology and the mechanistic study of calcium signaling pathways. -
Calcium Channel Inhibitor
Heteroclitin D is a lignan derived from Kadsura medicinal plants, functioning primarily as a calcium channel inhibitor. It exhibits significant biological activity by inhibiting L-type calcium channels, which are critical in various physiological processes. This compound is suitable for research applications focusing on calcium signaling, neuroprotection, and studies related to oxidative stress and lipid peroxidation.
